
Gluvoiz PM 1mg/500mg/15mg Tablet SR
Marketer
Ellanjey Lifesciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Gluvoiz PM 1mg/500mg/15mg Tablet SR
Metformin/Sitagliptin/Pioglitazone extended-release tablets (1mg/500mg/15mg) offer a multi-faceted approach to managing elevated blood glucose. This combined therapy, used alongside a healthy diet and regular physical activity, aids in better blood sugar regulation for adults with type 2 diabetes. It enhances insulin efficiency, contributing to lower blood sugar. Always adhere to your physician's prescribed dosage and regimen for Gluvoiz PM. Take it with food to minimize digestive discomfort. If a dose is missed, take it promptly unless your next dose is imminent; then, omit the missed dose and resume your usual schedule. Never double a dose. Excessive intake can result in dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol consumption, or skipped meals increases the risk of hypoglycemia. Regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, increased fracture risk, and respiratory infections. Prior to commencing treatment, inform your doctor of any kidney, liver, or heart conditions. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption to mitigate the potential for adverse reactions.
Uses of Gluvoiz PM 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Gluvoiz PM 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the Gluvoiz PM 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
Common Side effects of Gluvoiz PM 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Gluvoiz PM 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gluvoiz PM 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
How Gluvoiz PM 1mg/500mg/15mg Tablet SR works:
Gluvoiz PM SR tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thereby reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Gluvoiz PM 1mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Gluvoiz PM 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Gluvoiz PM tablets (1mg/500mg/15mg) are likely not safe for use while breastfeeding. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when administering Gluvoiz PM 1mg/500mg/15mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. The use of Gluvoiz PM 1mg/500mg/15mg SR tablets is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Gluvoiz PM 1mg/500mg/15mg Tablet SR, potentially requiring dosage modification. Medical advice is recommended. Gluvoiz PM 1mg/500mg/15mg Tablet SR is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Gluvoiz PM 1mg/500mg/15mg Tablet SR :
Should you forget a Gluvoiz PM 1mg/500mg/15mg Tablet SR dose, take it immediately if possible. However, near the time for your next dose, omit the missed dose and resume your usual schedule. Never take a double dose.
Facts to Know About Gluvoiz PM 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
